Telemus Capital’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-88
Closed -$8K 492
2017
Q4
$8K Buy
+88
New +$8K ﹤0.01% 532